ibrutinib treatment in patients with chronic lymphocytic leukemia(passive) caused byplatelet dysfunction
therapy with PLP , the active metabolite of vitamin B6(passive) caused byplatelet dysfunction
Long pump runscan causeplatelet dysfunction
Angelillo - Scherrer , A , et al . Deficiency or inhibition of Gas6causesplatelet dysfunction
eptifibatide in healthy volunteers(passive) caused byplatelet dysfunction
Ibrutinib treatment in patients with Chronic Lymphocytic Leukemia and potential reversal by Desmopressin administration(passive) caused byplatelet dysfunction
cyclooxygenase inhibition from saw palmetto(passive) caused byplatelet dysfunction
in accelerated platelet destruction by the reticuloendothelial cells in the spleen and liverresultin accelerated platelet destruction by the reticuloendothelial cells in the spleen and liver
to significant lung protectionleadsto significant lung protection
a decrease in tumor proliferation and delays vessel maturationcausesa decrease in tumor proliferation and delays vessel maturation
in a high concentration of healing and growth factors that stimulate tissue repair and regenerationresultsin a high concentration of healing and growth factors that stimulate tissue repair and regeneration
hemorrhagecausedhemorrhage
wound healingto provokewound healing
a decrease in tumor proliferation and delays vessel maturation [ 7causesa decrease in tumor proliferation and delays vessel maturation [ 7
to contraction of the tissues hence making our skin firmerleadsto contraction of the tissues hence making our skin firmer
to attenuation of metastatic depositsledto attenuation of metastatic deposits
Mild to moderate thrombocytopenia(passive) is caused byMild to moderate thrombocytopenia
neonatal alloimmune thrombocytopenia and posttransfusion purpuracan causeneonatal alloimmune thrombocytopenia and posttransfusion purpura
within the coronary circulation in fatal myocardial infarctionare discoveredwithin the coronary circulation in fatal myocardial infarction
to neuronal glutamate receptor dysfunctioncontributesto neuronal glutamate receptor dysfunction
to haemolysisleadingto haemolysis
to haemolysis and the formation of schistocytesleadingto haemolysis and the formation of schistocytes
in bleeding similar to that of Glanzmann Thrombastheniaresultingin bleeding similar to that of Glanzmann Thrombasthenia
to face over worries related to thin hairs by providing dense thicker hairsis contributingto face over worries related to thin hairs by providing dense thicker hairs
to platelet refractorinessleadingto platelet refractoriness
to accumulation of cAMP within plateletsleadsto accumulation of cAMP within platelets
to frequent epistaxisleadingto frequent epistaxis
thromboembolism(passive) caused bythromboembolism
to accumulation of cAMPleadsto accumulation of cAMP
to enhanced bleedingmay leadto enhanced bleeding
anemia and thrombocytopeniacausinganemia and thrombocytopenia
to a higher risk for vascular complicationsmay contributeto a higher risk for vascular complications
to the propensity for thrombosismay contributeto the propensity for thrombosis
to the diabetic prothrombotic statefurther contributesto the diabetic prothrombotic state
from their electrolytic productionresultingfrom their electrolytic production